Global Emerging Infections Surveillance and Response System Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2006
NCT00479206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (4)

artesunate (3 trials)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

mefloquine (lariam) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4